D-dimer from central and peripheral blood samples in asymptomatic central venous catheter-related thrombosis in patients with cancer

Phlebology. 2019 Feb;34(1):52-57. doi: 10.1177/0268355518772171. Epub 2018 Apr 24.

Abstract

Objectives: To evaluate the usefulness of a negative D-dimer in peripheral or central venous blood to screen for asymptomatic catheter-related thrombosis in cancer patients.

Methods: D-dimer was measured in blood from central venous catheter and peripheral venous samples in 48 patients with cancer. Asymptomatic catheter-related thrombosis was identified via Doppler ultrasound. Bland and Altman's limits of agreement analysis was used to compare sample sites. Sensitivity and specificity of D-dimer was calculated.

Results: Overall, 33 of the central samples and 32 of the peripheral samples had D-dimer levels below the cutoff (≥0.3 mg/l). Mean central D-dimer was 0.31 ± 0.35 mg/l; peripheral 0.24 ± 0.22 mg/l (p = 0.5). Bland-Altman plot showed that the two sample sites were not equivalent. Catheter-related thrombosis was demonstrated in five patients, and there were three false negatives. Peripheral D-dimer had a negative predictive value of 90.9%.

Conclusions: A negative D-dimer may be useful for screening asymptomatic catheter-related thrombosis in patients with cancer, but the central and peripheral sample sites are not equivalent.

Keywords: D-dimer; catheter-related thrombosis; central venous catheter; deep vein thrombosis.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Catheters / adverse effects*
  • Female
  • Fibrin Fibrinogen Degradation Products / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Neoplasms / blood*
  • Neoplasms / diagnostic imaging*
  • Neoplasms / therapy
  • Thrombosis / blood*
  • Thrombosis / diagnostic imaging*
  • Thrombosis / etiology
  • Ultrasonography, Doppler*

Substances

  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D